Optiver Holding
RCKT icon

Optiver Holding’s Rocket Pharmaceuticals RCKT Stock Holding History

Optiver Holding’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.7K Buy
12,484
+10,659
+584% +$42.4K ﹤0.01% 981
2025
Q4 		$6.41K Buy
1,825
+745
+69% +$2.55K ﹤0.01% 1264
2025
Q3 		$3.52K Buy
+1,080
New +$3.4K ﹤0.01% 2066

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Optiver Holding's RCKT Position: Q1 2026 in Review

Optiver Holding increased its Rocket Pharmaceuticals (RCKT) stake by 584% in Q1 2026, buying an estimated $42.4K and bringing the position to 12,484 shares worth $44.7K. The position accounts for ﹤0.01% of the portfolio, ranked #981.

Optiver Holding first reported a position in RCKT in Q3 2025 and has held it in 3 quarters since. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Optiver Holding held 12,484 shares of Rocket Pharmaceuticals worth $44.7K as of Q1 2026.
  • Optiver Holding bought 10,659 Rocket Pharmaceuticals shares in Q1 2026, an estimated $42.4K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #981 holding.
  • Optiver Holding first reported a position in Rocket Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.